๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current and future treatments for cognitive deficits in dementia

โœ Scribed by Beth M. McLendon; Gerome G. Chen; P. Murali Doraiswamy

Publisher
Springer
Year
2000
Tongue
English
Weight
99 KB
Volume
2
Category
Article
ISSN
1523-3812

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Drug treatments for cognitive impairment
Drug treatments for cognitive impairment due to ageing and disease: Current and future strategies
โœ Jonathan H. Dowson ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 834 KB

As the pathological changes in Alzheimer dementia include degeneration of cholinergic neurones, several strategies have been used to enhance the activity of remaining cholinergic neurones, including the administration of anticholinesterases. Other drugs which have been claimed to have a beneficial e

Cognitive deficits in olivopontocerebell
Cognitive deficits in olivopontocerebellar atrophy: Implications for the cholinergic hypothesis of Alzheimer's dementia
โœ Dr. Stephen J. Kish; Munir El-Awar; Lawrence Schut; Larry Leach; Marchlene Oscar ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 689 KB

A cerebral cortical cholinergic reduction in dominantly inherited olivopontocerebellar atrophy (OPCA) was recently described. Although the magnitude of the cholinergic reduction was similar to that observed in Alzheimer's disease (AD), none of the OPCA patients was reported to have been demented. We